BridgeMD
New treatment option for Cancer
Official title Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
ClinicalTrials.gov ID: NCT06927050
What this study is testing
- What it's testing
- This is a study in patients with newly diagnosed cancer to prospectively evaluate the feasibility of integration of a visual communication tool for patients/caregivers/providers by determining whether such a tool can increase overall satisfaction with the patient experience.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- Patients:
- Patients seen in consultation from 12/1/2024-6/1/2025
- Patients aged 18 years to 100 years old
- Patients with a malignancy of breast or head and neck
- English speaking patients
You likely can't join if
- above.
- Willing and able to provide consent Providers:
- Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department.
- Willing and able to provide consent
- aged 18 years to 100 years old Exclusion Criteria: Patients:
- Patients with any other site of disease other than listed above
See the full eligibility criteria
- Patients:
- Patients seen in consultation from 12/1/2024-6/1/2025
- Patients aged 18 years to 100 years old
- Patients with a malignancy of breast or head and neck
- English speaking patients
- Patients being treated with definitive intent
- Patients treated at NYU Langone Health for their malignancy
- Willing and able to provide consent Caregivers:
- Any adult caregiver(s) (aged 18 years to 100 years old) to a patient who fulfills the inclusion and
- above.
- Willing and able to provide consent Providers:
- Doctors and nurse practitioners in medical oncology and radiation oncology, and in the ear nose throat (ENT) department.
- Willing and able to provide consent
- aged 18 years to 100 years old Exclusion Criteria: Patients:
- Patients with any other site of disease other than listed above
- Non-English-speaking patients, as the tool is currently available in English only. Translation into additional languages such as Spanish and Russian is currently in process.
- Patient unable to complete the survey portion of the study independently Caregivers:
- Unable to complete the survey portion of the study independently
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.